Abstract-Oral NaCl produces a greater natriuresis and diuresis than the intravenous infusion of the same amount of NaCl.
H ypertension with its complications is currently a paramount problem imperiling human health, which is caused by the combined effects of environmental and genetic factors. 1 There is general agreement that salt (NaCl) intake is one such environmental factor, 2, 3 and epidemiological studies have shown a positive correlation between sodium intake and blood pressure. 4 Thus, limiting salt intake and promoting sodium excretion are effective in the treatment of sodium-induced hypertension, keeping in mind that there may be a J-shaped relationship between sodium intake and mortality. 5 Indeed, in some individuals, blood pressure may actually increase with a low sodium intake. 6 The kidney, especially the renal proximal tubule (RPT), which is responsible for ≈60% of total renal sodium reabsorption, is critical in the regulation of sodium balance. [7] [8] [9] We and others have reported that renal dopamine, via , plays an important role in preventing volume expansion by increasing sodium excretion secondary to a decrease in renal sodium reabsorption in several nephron segments, including the RPT. [8] [9] [10] At least 50% of basal sodium excretion in moderately volume-expanded states is mediated by the paracrine action of renal dopamine exerted on D 1 Rs. 9, 10 Dopamine, via D 1 R, inhibits the activity of Na + -K + -ATPase in the basolateral membrane and the Na + /H + exchanger, isoform 3 in the apical membrane of RPT cells. 8, [10] [11] [12] [13] [14] A dysfunction of the D 1 R is involved in the pathogenesis of hypertension. [8] [9] [10] Depending on the state of sodium balance, an oral NaCl load has been reported to produce stronger natriuresis and diuresis than an intravenous infusion of the same amount of NaCl, indicating the existence of a gastro-renal axis. [15] [16] [17] [18] Several hormones secreted by the stomach and duodenum have been suggested
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to be effectors of the gastro-renal axis. [16] [17] [18] [19] [20] [21] [22] An effector of the gastro-renal axis may be gastrin, produced by the G cells of stomach antrum and duodenum. 16, 20, 21 Food intake increases circulating gastrin levels 16, 20, 21 10-to 20-fold more than those of cholecystokinin (CCK), 22 and of all the gut hormones, gastrin is the one that is taken up the most by RPTs. 23 Furthermore, the gastrin receptor, also called cholecystokinin B receptor (CCK B R), is expressed in the kidney, including glomerular mesangial cells, collecting duct cells, and proximal convoluted tubule cells. 16, 21, 24, 25 In addition, stimulation of CCK B R promotes natriuresis. 21, 24, 25 However, as aforementioned, we and others have suggested that the renal dopaminergic system is important for the excretion of an oral or an intravenous sodium load. [8] [9] [10] Therefore, we tested the hypothesis that gastrin interacts with dopamine receptors in the kidney to synergistically increase sodium excretion. We hypothesized, further, that this interaction is impaired in hypertension. To verify the hypotheses, we studied the natriuretic effect of intrarenal arterial infusion of gastrin with or without coinfusion of a D 1 -like receptor agonist, fenoldopam, in the presence or absence of their respective antagonists, CI-988 (CCK B R antagonist) 26 and SCH23390 27, 28 (D 1 -like receptor antagonist), in the normotensive Wistar-Kyoto (WKY) rat and the spontaneously hypertensive rat (SHR). We also studied the colocalization and physical and functional interactions between CCK B R and D 1 R in rat RPT cells.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

In Vivo Study
Intrarenal Infusion of Gastrin Induces Natriuresis and Diuresis in WKY Rats But Not SHRs
To determine the effect of renal CCK B Rs on sodium excretion and urine flow, varying doses of gastrin (0, 0.1, 0.5, 1.0, 5.0 μg/kg per minute for 40 minutes in each period; n=6) were infused into the right suprarenal artery of WKY rats. In WKY rats, the intrarenal arterial infusion of the vehicle (normal saline) into the right kidney had no effect on urine flow (V) or absolute sodium excretion (U Na V; Table S1 in the online-only Data Supplement), whereas gastrin increased V and U Na V. An increase in V was first observed at a dose of 0.5 μg/kg per minute, whereas an increase in U Na V was first observed at a dose of 1.0 μg/kg per minute ( Figure 1A and 1B, respectively). In contrast, gastrin had no effect on V and U Na V in SHRs ( Figure 1A and 1B). The right intrarenal infusion of gastrin had no effect on blood pressure in WKY rat (Table S1 ) and SHR (not shown).
To determine the specificity of the gastrin effect on urine flow and sodium excretion, a gastrin receptor (CCK B R) antagonist, CI-988, was used. CI-988, infused at 1.0 mg/kg per minute, did not affect V and U Na V in WKY rats (Table S2) ; in the presence of CI-988, the diuretic and natriuretic effects of gastrin (1.0 μg/kg per minute) were blocked (Table S3) .
Stimulation of Renal D 1 -Like Receptors Induces Natriuresis and Diuresis in WKY Rats
To determine the effect of D 1 -like receptors on natriuresis and diuresis, varying doses of fenoldopam (0, 0.1, 0.5, 1.0, 5.0 μg/kg per minute for 40 minutes in each period; n=6) were infused into the right kidney (via the right suprarenal artery) in WKY rats. The intrarenal arterial infusion of fenoldopam increased V and U Na V. An increase in V was first observed at a dose of 0.5 μg/kg per minute, whereas an increase in U Na V was first observed at a dose of 1.0 μg/kg per minute (Figure 2A and 2B). The impaired natriuretic and diuretic effects of dopamine and D 1 -like receptor agonists, including fenolodopam, in SHRs have been reported 10, 29 ; therefore, this experiment was not performed in the current study.
A D 1 -like receptor antagonist, SCH23390, was used to determine the specificity of the D 1 -like receptors agonist (fenoldopam) on renal function. SCH23390, infused at a low dose of 0.4 μg/kg per minute, did not affect V and U Na V in WKY rats (Table S4 ). In the presence of SCH23390, the natriuretic and diuretic effects of fenoldopam were blocked in WKY rats (Table S5) . Figure S1A and S1B). In contrast, the inhibitory (0.4 μg/kg per minute; n=5), or in combination (gastrin+SCH23390, n=5; gastrin+CI-988, n=6) on urine flow (V; A) and absolute sodium excretion (U Na V; B). During the control period, only the vehicle (saline) was infused. During period 1 (P1), the vehicle (saline) was infused in the gastrin group; CI-988 was infused in the vehicle+CI-988 and gastrin+CI-988 groups; SCH23390 was infused in the vehicle+SCH23390 and gastrin+SCH23390 groups. During periods 2 to 3 (P2, P3), gastrin, instead of vehicle, was infused in the gastrin+SCH23390 and gastrin+CI-988 groups. In the recovery period, only the vehicle (saline) was infused in all the groups. Data are expressed as mean±SEM. *P<0.05 vs other groups (factorial ANOVA, Holm-Sidak test). C and D, The fenoldopam-mediated diuresis and natriuresis were blocked by gastrin receptor antagonist (CI-988) in WKY rats. Effect of the D 1 -like receptor agonist fenoldopam (1.0 μg/kg per minute; n=5), D 1 -like receptor antagonist SCH23390 (0.4 μg/kg per minute; n=5), or in combination (fenoldopam+CI-988, n=6; fenoldopam+SCH23390, n=5) on V (C) and U Na V (D). During the control period, only the vehicle (saline) was infused. During period 1 (P1), the vehicle (saline) was infused in the fenoldopam group; CI-988 was infused in the vehicle+CI-988 and fenoldopam+CI-988 groups; SCH23390 was infused in the vehicle+SCH23390 and fenoldopam+SCH23390 groups. During periods 2 to 3 (P2, P3), fenoldopam, instead of vehicle, was infused in the fenoldopam+SCH23390 and fenoldopam+CI-988 groups. In the recovery period, only the vehicle (saline) was infused in all the groups. Data are expressed as mean±SEM. *P<0.05 vs other groups (factorial ANOVA, Holm-Sidak test).
In Vitro Study
effect of gastrin (10 -9 mol/L) on Na + -K + -ATPase activity was not observed in SHR RPT cells ( Figure S1C ).
The receptor specificity of the inhibitory effect of gastrin on Na + -K + -ATPase activity was also studied. CI-988 (10 -5 mol/L for 15 minutes), by itself, had no effect on the basal Na + -K + -ATPase activity, but in the presence of CI-988, the inhibitory effect of gastrin (10 -9 Previous studies [29] [30] [31] [32] have shown that the inhibitory effect of D 1 -like receptor agonists on renal or RPT Na + -K + -ATPase activity is impaired in the SHR. We also studied the effect of fenoldopam on Na + -K + -ATPase activity in WKY RPT cells. We found that SCH23390 (10 -6 mol/L for 15 minutes), by itself, had no effect on the basal Na + -K + -ATPase activity but blocked the inhibitory effect of fenoldopam (10 -7 Figure S4A ). Cell-surface D 1 R but not CCK B R expression was also lesser in SHRs than in WKY rats. The ability of fenoldopam to increase cell-surface D 1 R expression was blocked by both CCK B R and D 1 R antagonists, which by themselves had no effect ( Figure S4B ).
Gastrin Receptors (CCK B Rs) Colocalize With D 1 Rs in RPT Cells
To confirm the potential for a direct or indirect interaction between gastrin (CCK B R) and D 1 Rs, we studied the colocalization of gastrin (CCK B R) and D 1 Rs in RPT cells from WKY rats. Immunofluorescence laser confocal microscopy showed that gastrin (CCK B R) and D 1 Rs were found throughout the cell and, with evidence of colocalization, especially in the plasma membrane (Figure 4) . To demonstrate the specificity of the antibodies for CCK B R and D 1 Rs, these antibodies were preincubated with their corresponding immunizing peptides (1:10 wt/wt incubation for 12 hours). The staining for TRITC (tetramethyl rhodamine isothiocyanate)-tagged CCK B R (red) and fluorescein isothiocyanate-tagged D 1 R (green) was no longer visible when the CCK B R antibody was incubated with the CCK B R immunizing peptide and the D 1 R antibody was incubated with the D 1 R immunizing peptide ( Figure S5 ).
To determine whether there is a physical interaction between gastrin (CCK B R) and D 1 Rs, a coimmunoprecipitation study was performed; gastrin receptors were first immunoprecipitated with anti-gastrin (CCK B R) receptor antibodies, and the coimmunoprecipitates were immunoblotted with anti-D 1 R antibodies. The CCK B R/D 1 R coimmunoprecipitation was increased with gastrin (10 -9 mol/L for 15 minutes) treatment in WKY RPT cells but not in SHR RPT cells; similar results were obtained after treatment with fenoldopam ( Figure 5A and 5B).
Discussion
As indicated earlier, depending on the state of sodium balance, an oral NaCl load produces a stronger diuresis and natriuresis than an intravenous infusion of the same amount of NaCl. 15, 16 In addition to neural mechanisms, several gut hormones (eg, CCK, uroguanylin) have been proposed to mediate the natriuresis of an oral NaCl load. [16] [17] [18] [19] [20] [21] Although a high NaCl intake increases renal uroguanylin expression, it may not always increase circulating uroguanylin levels. 16, 17, 33, 34 Guca2b
mice have an impaired natriuretic response to an acute oral NaCl load, but blood pressure is only slightly increased and salt sensitivity is similar to that of Guca2b +/+ mice. 18 CCK is natriuretic, 16, 19 but circulating CCK levels are not increased by an oral NaCl load 35 and CCK is not taken up by renal tubules. 23 Food intake increases circulating gastrin levels 10-to 20-fold more than those of CCK, 22 and of all the gut hormones tested, gastrin is taken up the most by RPTs 23 ; therefore, gastrin is a good candidate for the gastro-renal reflex. Furthermore, the oral intake of NaCl, without food, increases circulating gastrin levels (P.A. Jose PA et al, unpublished data, 2012). The gastrin receptor, CCK B R, is expressed in specific nephron segments, including the proximal tubule. 16, 21, 24, 25 Furthermore, gastrin is important for the excretion of an ) do not have a natriuresis after ingestion of food 21 and develop salt-sensitive hypertension (P.A. Jose et al, unpublished data, 2012). Our current study confirmed the diuretic and natriuretic effects of gastrin in WKY rats and found that the natriuretic effect of gastrin is, in part, via the inhibition of Na + -K + -ATPase activity. However, in SHRs, the diuretic and natriuretic effects of gastrin, as well as its inhibitory effect on Na + -K + -ATPase activity, are lost. These results may, at first glance, be taken as contradictory to our previous report that the intrarenal infusion of sulfated CCK octapeptide produced a similar natriuretic and diuretic effect in WKY and SHRs. 36 However, sulfated CCK octapeptide has a much greater affinity to CCK A R than CCK B R, whereas gastrin has a much greater affinity to CCK B R than CCK A R. 20 Indeed, the natriuretic and diuretic effects of gastrin were blocked by the selective CCK B R antagonist, CI-988 26, 37 . Although CCK B R is expressed in the renal proximal tubule, 24, 25 CCK A R is not. 38 In addition to gastrin, dopamine, a catecholamine produced endogenously by the renal proximal tubule, plays an important role in the regulation of sodium excretion and blood pressure. [8] [9] [10] Several studies have shown that the natriuretic effect of dopamine is mainly exerted via D 1 -like receptors. 8, 10, 28, 29, 39 Consistent with previous reports, 29, 31, 32 we found that renal D 1 -like receptor-mediated diuresis and natriuresis are impaired in SHRs. The impaired diuretic and natriuretic effects of D 1 -like receptors in the SHR 29, 31, 32 are due, in part, to hyperphosphorylation and desensitization of the renal D 1 R because of increased constitutive activity of the G-protein-coupled receptor (GPCR) kinase types 2 and 4. [8] [9] [10] 30, [40] [41] [42] Several other GPCRs and hormones/humoral factors negatively interact with the D 1 R, including aldosterone, 42 and α-adrenergic receptors, 43 AT1R27, 44 insulin, 45 and renin. 46 Although several GPCRs and other hormones/humoral factors have been reported to positively interact with the D 1 R in the regulation of sodium excretion, including atrial natriuretic peptide/ANPA (atrial natriuretic peptide A), 47 AT 2 R, 48 nitric oxide, 49 and prolactin, 50 the role of such interactions in hypertension has not been reported. Our present study found that CCK B R is another GPCR that positively interacts with the D 1 R in the regulation of sodium excretion. As indicated above, both gastrin and fenoldopam induced diuresis and natriuresis in WKY rats. However, in the presence of a CCK B R antagonist, the fenoldopam-mediated diuresis and natriuresis are blocked and vice versa, that is, a D 1 -like receptor antagonist blocks the diuretic and natriuretic effects of gastrin. However, whether Na + balance and blood pressure regulation are the results of a net positive and negative interactions among D 1 R, other dopamine receptor, and other GPCRs remain to be determined.
We also sought to elucidate the underlying mechanism regulating the interaction between renal CCK B R and D 1 + -ATPase activity are lost, and their synergism is no longer evident. Whether the synergistic inhibitory effect of CCK B R and D 1 R on sodium transport involves signaling mechanisms, in addition to direct protein/protein interaction, will be determined in the future.
In conclusion, we have demonstrated that gastrin, via CCK B R, interacts with D 1 -like receptors, specifically D 1 R in the kidney, synergistically increasing water and sodium excretions, effects that are not observed in SHRs. An impaired interaction among GPCRs, CCK B R, and D 1 R, for instance, in the regulation of renal sodium excretion may be important for the pathogenesis of hypertension.
Perspectives
The intrarenal infusion of gastrin or fenoldopam induces diuresis and natriuresis; CCK B R and D 1 -like receptors synergistically increase sodium excretion in WKY rats. However, in SHRs, both the diuresis and natriuresis mediated by CCK B R or D 1 -like receptors are no longer observed. Previous studies 
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have shown that the D 1 R dysfunction in hypertensive states is because of the hyperphosphorylation and uncoupling of D 1 R from its G protein-effector complex, caused by increased constitutive activity of GPCR kinases 2 and 4. [8] [9] [10] 30, [40] [41] [42] Whether GPCR kinases regulate CCK B R is not known. We hypothesize that GPCR kinases impair CCK B R receptor function, including the interaction between CCK B R and D 1 R, in SHRs, which need to be confirmed in the future.
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What Is New? 
Animal Surgery
Male WKY and SHRs (SLRC Laboratory Animals, Shanghai, China), ranging in age from 9 to 16 weeks, fed a regular and normal sodium (0.4% NaCl) rat chow were used. Food but not water was withheld 24hrs before the study. Prior to the performance of the experiments, the rats were anesthetized with pentobarbital (50 mg/kg body wt, intraperitoneally), placed on a heated table to maintain rectal temperature between 36 and 37 , and tracheotomized (PE-240). Anesthesia was maintained by the infusion of pentobarbital sodium at 0.8 mg/100 g body wt per hr 1 . Catheters (PE-50) were placed into the external jugular and femoral veins, for fluid replacement, and carotid artery, for monitoring systemic arterial pressure (Cardiomax II; Columbus Instruments, Columbus, OH, USA). A laparotomy was performed and both the right and left ureters were catheterized (PE-10). The right renal artery was exposed, and the right suprarenal artery, which originates from the right renal artery, was catheterized (PE-10 heat stretched to 180 um) for vehicle (saline) or drug infusion at a rate of 40 ul/h 1 . The total duration of the surgical procedures was about 60 min. Fluid losses during surgery were replaced with 5% albumin in normal saline at 1% body weight over 30 min. After an equilibration period of 120 min, urine was collected every 40 min, five times, for clearance measurements. All studies were approved by the Daping Hospital Animal Care and Use Committee.
Studies on Renal Function In Vivo
2.1. Dose-response infusion: After a baseline period, the WKY and SHRs were infused, through the right suprarenal artery, with gastrin and fenoldopam at a dose of 0.1, 0.5, 1.0, and 10.0 mg/kg/min 2 . Thereafter, the infusate was changed to the vehicle for the recovery period; each period lasted 40 min.
Single-dose infusion:
The WKY rats were divided into 8 groups. Control Group. Normal saline (vehicle) was infused into the right suprarenal artery.
Gastrin/Fenoldopam Group. Two baseline periods were obtained. Thereafter, gastrin and/or fenoldopam was infused (1.0 mg/kg/min) for two time periods, followed by one recovery period in which the drug infusion was stopped but the vehicle infusion was continued for another 40 min.
CI-988/SCH23390 Group. CI-988 (1.0 mg/kg/min) 3 or SCH223390 (0.4 ug/kg/min) 1 was infused during the second period after one baseline period and continued for two periods followed by recovery in order to determine the effect of blockade of gastrin or D 1 -like receptors on basal renal function.
Gastrin+CI-988/Fenoldopam+SCH23390 Group. To determine the specificity of the gastrin and fenoldopam effects, a CCK B R antagonist, CI-988 3 , or D 1 -like receptor antagonist, SCH23390 1, 4 , was infused during the second baseline period, and then co-infused with gastrin or fenoldopam separately for two periods, followed by recovery.
Gastrin+SCH23390/ Fenoldopam+CI-988 Group. To explore the interaction between D 1 -like and gastrin receptors, SCH23390 or CI-988 was infused during the second baseline period, and then co-infused with gastrin or fenoldopam separately for two periods, followed by recovery.
The rats were sacrificed by an overdose of pentobarbital (100 mg/kg body wt). Sodium and potassium concentrations in serum and urine samples were analyzed. Urine flow, absolute and fractional sodium (U Na V, FENa) and potassium (U K V, FEK) excretions were calculated 1, 2 .
Cell Culture
Immortalized RPT cells from microdissected S 1 segments of proximal tubules of 4-to 8-week-old WKY and SHRs were cultured at 37 °C in 95% air/ 5% CO 2 atmosphere in DMEM/F-12 with transferrin (5 ug/ml), insulin (5 ug/ml), epidermal growth factor (10 ng/ml), dexamethasone (4 ug/ml), and FBS 5% in a 25 cm cell culture flask 5 . For subculturing, cells were dissociated with 0.25% trypsin, split in 6-well plates or Petri dishes. Cells were made quiescent by incubation for 2 hrs in medium without FBS before the addition of drugs. ) for ouabain-sensitive ATPase activity. Then they were preincubated for 5 min in water bath at 37 °C. The reaction was initiated by the addition of 160 mM ATP and terminated after 20 min of incubation at 37 °C by adding 50 ul of ice-cold 50% trichloroacetic acid solution. The tubes were transferred onto ice and kept for 5min. To quantify the amount of phosphate produced, 1ml of coloring reagent (5% Fe 2 SO 4 in 10% ammonium molybdate in 10 N H 2 SO 4 ) was added and then centrifuged at 3000 g for 3 min after thorough mixing. The liberated inorganic phosphate (Pi) was determined by measuring the absorbance at 740 nm against a standard curve prepared from K 2 HPO 4 . Na 
Cell Surface Protein Expression
Cultured RPT cells were starved in serum-free medium for 2 hr, and then treated with reagents at the indicated concentrations and durations of incubation. Surface membrane proteins were biotinylated by adding sulfo-NHS-LC-biotin (final concentration 250 ug/ml) into the medium 30 min before the end of the reagent treatment 10 . The cells were washed 3 times with ice-cold phosphate-buffered saline (PBS), lysed with an ice-cold lysis buffer (PBS with 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF, 10 g/ml aprotinin, and 10 ug/ml leupeptin), sonicated, placed on ice for about 1 hr, and centrifuged at 16000 g for 30-45 min. The supernatant from the cell lysate was immunoprecipitated with the polyclonal goat anti-rat D 1 R antibody (SC-31478, Santa Cruz Biotechnology, USA) or rabbit anti-rat CCK B R antibody (AP01421PU-N, Acris Antibodies, Germany), followed by immunoblotting. The membrane sheets were blocked with 5% milk overnight, washed with TBST buffer (1 M pH 7.4 Tris-HCl, 0.9 g NaCl and 100% Tween-20) for 3 times, and incubated with peroxidase-conjugated streptavidin (1:4000-1:5000 dilution, 30 min; Jackson ImmunoResearch Laboratory). The biotinylated protein bands were visualized by enhanced chemiluminescence (Western Blotting Detection Kit; Thermo Scientific, USA).
Immunofluorescence Confocal Microscopy of Double-Stained RPT Cells
RPT cells, grown on coverslips, were fixed with 4% paraformaldehyde (30 min), permeabilized with 0.05% Triton-100 in phosphate-buffered saline (20 min) and blocked with normal goat serum (1 hr). Reactions with antibodies were performed as described previously 8, 10 . The D 1 R was visualized using the goat anti-D 1 R antibody (1:25-1:50) followed by a fluorescein isothiocyanate (FITC); conjugated CCK B R (gastrin receptor) was visualized using the rabbit anti-CCK B R antibody (1:50-1:100), followed by a rhodamine (TRITC)-conjugated affinity-purified goat anti-rabbit secondary antibody (red; Molecular Probes). Cells on coverslips were mounted with the ProLong Antifade Kit (Molecular Probes). Immunofluorescence densities and images were acquired (Olympus AX70 laser confocal microscopy) at an excitation wavelength of 488 and 547 nm; emission was detected at 535 and 572 nm.
Immunoprecipitation
Immortalized RPT cells were incubated with vehicle, gastrin (10 -9 M) or fenoldopam (10 -7 M) for 15 min. The cells were lysed with ice-cold lysis buffer for 1 hr and centrifuged at 16000 g for 30-45 min. Equal amounts of lysates (5 ug protein/ l supernatant for RPT cells from both WKY and SHRs) were incubated with affinity-purified anti-CCK B R antibody (5 ug/ml) for 1 hr and protein G plus-agarose at 4 °C for overnight. The immunoprecipitates were pelleted and washed 3 times with PBS. The pellets were suspended in sample buffer, boiled for 10 min, and subjected to immunoblotting with the D 1 R antibody. The densities of the bands were quantified by densitometry using Quantiscan (Ferguson, MO, USA), as previously reported 8, 10 .
Materials
Rabbit anti-rat gastrin and goat anti-rat D 1 R antibodies were both purchased from Santa Cruz Biotechnology Inc. Gastrin (Gastrin I rat) was purchased from Sigma and fenoldopam (Fenoldopam hydrochloride; 1659) was purchased from Tocris Bioscience. Peroxidase-conjugated streptavidin was purchased from Jackson ImmunoResearch Laboratory, Inc (West Grove, PA, USA). Sulfo-NHS-LC-biotin was purchased from Thermo Scientific Inc. Other chemicals for various buffers were of the highest purity available and purchased either from Sigma or Gibco. 
